After many years of success, EvidenceNetwork.ca is no longer in operation. We would like to thank everyone who has contributed to the organization over the past decade including our dedicated researchers, newspaper editors, readers and funders. However, now it is time to move onto new ways of looking at knowledge mobilization and policy. Should you have any questions, please feel free to contact Shannon Sampert at [email protected].
Evidence Network

It is time to talk about the overuse of antipsychotics among adults with developmental disabilities

By Yona Lunsky and Tara Gomes Comments Off on It is time to talk about the overuse of antipsychotics among adults with developmental disabilities , , , , , , , , , ,

Inappropriate prescribing of antipsychotic medications — drugs like Risperdal, Zyprexa and Abilify — to seniors, especially those in long-term care with conditions like dementia, has been a hot topic of discussion across Canada in recent years. We have also increasingly heard about the high numbers of these medications being prescribed to children and youth with […]